406 filings
Page 5 of 21
8-K
c7iuam1bd013y4
5 Jan 23
Regulation FD Disclosure
5:01pm
8-K
2maw 4gijdhnk
30 Dec 22
Termination of a Material Definitive Agreement
5:00pm
D
2w9eh8r
29 Dec 22
$30.00 mm in equity, sold $7.50 mm, 17 investors
3:12pm
S-8
sp50 foh3
22 Dec 22
Registration of securities for employees
5:37pm
8-K
f9stgi
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
8-K/A
7e61kw3f
16 Dec 22
Other Events
2:58pm
8-K
7amatvwoiykkf
15 Dec 22
Completion of Acquisition or Disposition of Assets
6:11am
8-K
n5p4q3f4052m0hcc8ki
13 Dec 22
Submission of Matters to a Vote of Security Holders
4:02pm
425
c9m 0wtxtmp0e1bm73
6 Dec 22
Business combination disclosure
4:04pm
8-K
hto46d wz7y
6 Dec 22
Regulation FD Disclosure
4:02pm
425
arc9nco
5 Dec 22
Business combination disclosure
9:28am
8-K
rjxrx61
5 Dec 22
Yumanity Therapeutics Declares Special Dividend In Connection with Proposed Asset Sale to Janssen and Merger with Kineta
9:27am
424B3
5rmkd93mod38 jhev
5 Dec 22
Prospectus supplement
9:22am
425
2658gy2rizl
1 Dec 22
Business combination disclosure
4:04pm
8-K
mhokvy0xbtwi
1 Dec 22
Kineta to Present KVA12123 VISTA Blocking Immunotherapy Program at Antibody Engineering and Therapeutics Conference
4:01pm
425
2nd yvi6q697hwspkyt
29 Nov 22
Business combination disclosure
4:03pm
8-K
116253h1 dj
29 Nov 22
Kineta to Participate in JMP Securities Hematology and Oncology Summit
4:01pm
425
ht0rnuk
28 Nov 22
Business combination disclosure
4:03pm
8-K
so8kmlzemt7b
28 Nov 22
Regulation FD Disclosure
4:01pm
SEC STAFF
fe6dsn5jf
17 Nov 22
SEC staff action: Order
12:00am